Read the latest applied chemistry highlights for November 2024 by Nigel P Freestone | University of Northampton, UK.
Read the organic chemistry highlights for November 2024 written by G. Richard Stephenson, University of East Anglia, UK.
Outdoors, solar energy has hit boom time, accounting for up to three-quarters of extra renewable energy capacity in 2023 and surpassing wind for the first time. Next, indoor solar will be crucial for powering the sensors and controls soon to become ubiquitous in our offices and homes. Anthony King reports
Artificial intelligence could help doctors spot antibiotic resistant bacteria. This is the conclusion from a Swiss study that trained GPT-4 from OpenAI to interpret lab tests on patient samples.
Researchers in California have pinpointed a location on a cancer protein that small molecules can target. Mutations in the protein, called Forkhead box protein 1 (FOXA1), allow some cancers to proliferate, but it has been notoriously difficult to block it with drugs.
The UK chemical industry has seen growth almost disappear, despite signs earlier in the year that growth had returned. The latest survey of the industry by the UK Chemicals Industry Association, reporting on Q3 trading, shows reductions across the board.
Pharma major GSK is to make its largest ever manufacturing investment in the US. Its Marietta, Pennsylvania, US, site will receive new state-of-the-art manufacturing facilities, while new R&D and commercial facilities will double the size and capacity of the site, representing a total investment of up to $800m.
On both sides of the Atlantic, investment in bioscience research is experiencing significant interest. The UK Biotechnology & Biological Sciences Research Council (BBSRC) is investing £4m in 23 ‘pioneering’ bioscience research technologies, methodologies and resources through its 2023 Transformative Research Technologies fund (23TRT).
A new technology that enables the easy and rapid editing of single key atoms responsible for drug efficacy could revolutionise the process of discovering potential drug candidates.